DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

Novavax, Inc. (NASDAQ: NVAX)

5.10 0.06 (1.19%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NVAX $5.10 1.19%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.12
Previous Close $5.04
Daily Range $5.00 - $5.21
52-Week Range $3.17 - $6.95
Market Cap $1.2B
P/E Ratio -16.80
Dividend (Yield) $0.00 (0.0%)
Volume 2,855,715
Average Daily Volume 4,718,123
Current FY EPS -$0.32





Novavax, Inc. (NVAX) Description

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases. Website:

News & Commentary Rss Feed

Why Novavax, Inc. Stock Skyrocketed 34% in October

Novavax was a top biotech stock in October with a massive 34% gain. See what made Novavax shares shoot to the moon, as well as whether or not its meteoric rise can continue.

Novavax Gains on Fast Track Designation for RSV F Vaccine - Analyst Blog

Novavax Gains on Fast Track Designation for RSV F Vaccine - Analyst Blog

Use Options For a Chance To Buy NVAX at a 50% Discount

Today's Dead Cat Bounce Stock: Novavax (NVAX)

Novavax Initiates Phase 2 Clinical Trial Of Quadrivalent Seasonal Influenza VLP

Molecular Biology Meets Finance: MLV's George Zavoico On Ebola's Silver Lining

Today's Dead Cat Bounce Stock Is Novavax (NVAX)

Novavax's (NVAX) CEO Stanley Erck on Q3 2014 Results - Earnings Call Transcript

Morning Market Movers

Benzinga's Top #PreMarket Gainers

See More NVAX News...

NVAX's Top Competitors

NVAX $5.10 (1.19%)
Current stock: NVAX
AMGN $162.81 (0.08%)
Current stock: AMGN
GILD $100.58 (-0.01%)
Current stock: GILD
BIIB $303.55 (1.49%)
Current stock: BIIB